University of Minnesota. Driven to Discover.
Some problems became more apparent with age, and the follow-up findings could help providers plan care for other babies born with Zika-related defects.
No link was found between microcephaly and a key insecticide—or vaccines.
Trials of both an inactivated and a DNA vaccine showed good safety and immune response data.
Japan-based Takeda announces the launch of a phase 1 trial of its Zika vaccine.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.